/PRNewswire/ Diadem srl, a company developing blood-based tests for the early prediction and diagnosis of Alzheimer s disease (AD), today announced that it.
/PRNewswire/ The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test.
/PRNewswire/ The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test.
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Diadem Srl today announced CE IVD certification for its AlzoSure® Predict prognostic blood test for the early prediction of Alzheimer s disease.